scholarly journals Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma

Author(s):  
Ceri Bygrave ◽  
Charlotte Pawlyn ◽  
Faith Davies ◽  
Zoe Craig ◽  
David Cairns ◽  
...  
2021 ◽  
Vol 2021 (5) ◽  
Author(s):  
Adam L Bumgardner ◽  
Kyle Yuan ◽  
Alden V Chiu

ABSTRACT Aphantasia, the loss of mental imagery, is a rare disorder and even more infrequent when acquired. No previous cases have been identified that were caused by transplant-related treatment. We describe a case of acquired aphantasia in a 62-year-old male with refractory IgG kappa multiple myeloma after receiving an autologous stem cell transplant (ASCT) following high-dose melphalan with a complicated hospital admission. The etiology of aphantasia remains unidentified, but we provide viable explanations to include direct effects from ASCT treatment and indirect effects from transplant-related complications.


2014 ◽  
Vol 55 (12) ◽  
pp. 2967-2969 ◽  
Author(s):  
Aleksandar Radujkovic ◽  
Michael Hundemer ◽  
Christoph Eisenbach ◽  
Thomas Luft ◽  
Roland Penzel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document